Bergeson & Campbell, P.C. (B&C) is pleased to announce the launch of our newly redesigned website, which has been streamlined to make it easier to navigate. The substantive and timely legal and regulatory information we provide remains available. This information covers a wide range of topics, including the Toxic Substances Control Act (TSCA), nanotechnology, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), Green Chemistry, the Food and Drug Administration (FDA), the Occupational Safety and Health Administration (OSHA), Proposition 65, the European Union’s (EU) Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) Program, endocrine disruptors, the Clean Air Act (CAA), the Clean Water Act (CWA), and related chemical and regulatory matters. The B&C website is available at www.lawbc.com. We are committed to providing our clients with top flight, timely information to assist them in their growing businesses, and we hope our new site assists our clients.
About Bergeson & Campbell, P.C. — Located in Washington, D.C., B&C is a law firm focusing on conventional and nanoscale industrial, agricultural, and specialty chemical product regulation and approval matters, including TSCA matters, FIFRA/FQPA matters, FDA medical device and product approval, registration and data compensation arbitrations, chemical product litigation, and associated business counseling and litigation issues. B&C’s clients are involved in many businesses, including conventional and nanoscale basic, specialty, and agricultural and antimicrobial chemicals; biotechnology, nanotechnology, and emerging transformative technologies; consumer products; medical devices and diagnostic products; paints and coatings; and plastic products. Additional information is available at www.lawbc.com.
About B&C Consortia Management, L.L.C. — BCCM, an affiliate of B&C, has strong institutional experience in consortia management. BCCM provides cost effective administrative and management services to consortia to ensure their interests are protected and their voices heard on issues of concern. BCCM works with industry groups to develop or expand advocacy and/or product stewardship programs, to develop and conduct communications outreach to local, state, federal, or international government entities, to formulate and initiate research programs — whether voluntary or in response to regulatory requirements, and many other activities. Additional information is available at www.bc-cm.com.
About The Acta Group, L.L.C. and The Acta Group EU, Ltd — Acta and Acta EU are consulting affiliates of B&C, established to control the spiraling costs and inefficiencies encountered by clients seeking approvals to market agricultural and industrial chemicals, products of biotechnology and nanotechnology, and Food and Drug Administration-regulated products. Acta and Acta EU manage products from concept to approval, utilizing the skills and experience of professionals who have worked in the specific product areas in government and industry. Additional information is available at www.actagroup.com.